Skip to main content
logo
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) (EGX:RMDA)
Egypt flag Egypt · Delayed Price · Currency is EGP
5.77
-0.03 (-0.52%)
At close: Aug 5, 2026

EGX:RMDA Financials Overview

Millions EGP. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
4,2974,0962,7691,9221,4841,246
Revenue Growth
35.21%47.94%44.03%29.54%19.06%29.81%
Gross Profit
2,1061,9821,284904.06718.67576.82
Operating Income
988.18962.45725.44445.76342.26274.29
Net Income
289.13268.61363.84223.5228.91166.39
Earnings Per Share
0.140.130.180.110.120.08
EPS Growth
-25.70%-26.23%60.98%-3.52%41.22%70.69%

Revenue by Segment
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Services Toll Manufacturing
318.2284.79181.87134.01132.4477.49
Production and Selling of Pharmaceutical Products
3,9793,8112,5871,7881,3521,169
Total
4,2974,0962,7691,9221,4841,246

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
44.0136.18254.39313.25428.82482.01
Total Debt
2,2872,4091,5661,114930.18879.94
Net Cash (Debt)
-2,243-2,372-1,312-801.18-501.37-397.93
Net Cash Growth
------
Net Cash Per Share
-1.11-1.18-0.65-0.40-0.26-0.20

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-68.1-43.67-306.92-44.529.35241.35
Capital Expenditures
-157.87-155.9-64.93-91.05-34.38-52.67
Free Cash Flow
-225.98-199.57-371.85-135.54-5.03188.68
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
49.02%48.39%46.38%47.03%48.43%46.28%
Operating Margin
23.00%23.50%26.20%23.19%23.06%22.01%
Pretax Margin
10.45%10.35%19.00%17.03%22.13%18.74%
Profit Margin
6.73%6.56%13.14%11.63%15.43%13.35%
FCF Margin
-5.26%-4.87%-13.43%-7.05%-0.34%15.14%

Dividends
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingAug '26 Dec '25 Dec '24 Dec '23
Dividend Per Share
0.040-0.0400.051
Dividend Per Share Growth
-62.69%--20.71%-
Dividend Yield
0.69%-1.64%4.32%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
40.4324.7913.8011.0012.6314.42
Forward PE
18.899.1910.847.729.2510.10
P/FCF Ratio
-----12.72
PS Ratio
2.701.631.811.281.951.93